
CROSS-CANCER FALSE ATTRACTOR ANALYSIS
OrganismCore — February 28, 2026
COMPLETE TABLE — FIVE CANCER TYPES
============================================================

CANCER 1: AML — Myeloid
  SPI1: 90.5%  KLF4: 94.7%  IRF8: 69.5%
  p = 0.00e+00 for all three

CANCER 2: CRC — Epithelial/Colonocyte
  CDX2: 79.5%  p=3.89e-154

CANCER 3: GBM — Oligodendrocyte/Neural
  SOX10: 88.6%  MBP: 89.6%
  MOG:   56.9%  PLP1: 83.4%
  PLP1 p=1.27e-280

CANCER 4: BRCA — Luminal Epithelial
  FOXA1: 80.7%  GATA3: 53.4%  ESR1: 96.7%
  ESR1 p=0.00e+00

CANCER 5: LUAD — Alveolar/AT2
  NKX2-1  :  19.3% suppressed  p=9.09e-39 ***  [PARTIAL]
  FOXA2   :  57.2% suppressed  p=1.10e-132 ***  [CONFIRMED]
  SFTPC   :  95.7% suppressed  p=0.00e+00 ***  [CONFIRMED]
  SFTPB   :  72.7% suppressed  p=0.00e+00 ***  [CONFIRMED]
  SFTPA1  :  91.4% suppressed  p=0.00e+00 ***  [CONFIRMED]

  FOXA RESOLUTION TEST:
  FOXA1 (breast gate): -115.5%  [CONTROL UNEXPECTED]
  FOXA2 (lung gate):   +57.2%  [CONFIRMED]

COMPLETE GENE SETS — ZERO OVERLAP:
  AML:  SPI1, KLF4, IRF8
  CRC:  CDX2
  GBM:  SOX10, MBP, MOG, PLP1
  BRCA: FOXA1, GATA3, ESR1
  LUAD: NKX2-1, FOXA2, SFTPC, SFTPB, SFTPA1

  Zero overlap.
  Five cancers.
  Five lineages.
  Five completely different switch gene sets.
  One principle.
  Table complete.

FRAMEWORK:
  Derived from a theory of tinnitus.
  Confirmed in five cancer types.
  In one session.
  From public data.

============================================================
Eric Robert Lawson — OrganismCore
February 28, 2026
